Navigating the Financial Landscape of Pediatric Dermatology: Compensation, Practice Models, and Billing Strategies

Sheilagh Maguiness, MD (University of Minnesota), Fred Ghali, MD (Pediatric Dermatology of North Texas), and Yvonne Chiu, MD (Medical College of Wisconsin) delivered a panel presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting addressing the financial realities of pediatric dermatology. The session covered relative value unit (RVU) benchmarks, structural pay inequities, private practice options, revenue diversification, and practical coding strategies to maximize practice reimbursement.

Dilemma and Specialty Representation

Maguiness opened the discussion by framing financial self-advocacy as an essential component of subspecialty sustainability. Pediatric dermatologists remain undercompensated by approximately 70% relative to adult dermatologists and other medical colleagues—a disparity driven by high Medicaid volumes, uncompensated non-clinical work, and flawed national benchmark data. Because pediatric subspecialties have small survey sample sizes, commercial benchmark reporting fluctuates wildly from year to year, rendering institutional salary comparisons unreliable. 

To address these structural gaps, the SPD published its own comprehensive compensation data set in 2025. The survey revealed rising median salaries across the subspecialty alongside significant pay variance, with clinicians in the 10th percentile earning half as much as those in the 90th percentile. While an academic salary penalty remains common, physicians embedded directly within pediatric departments generally report higher compensation than those in general dermatology departments. 

Crucially, in 2023, pediatric dermatology obtained official AMA specialty designation. This milestone established a dedicated seat on the CPT and RVS Update Committee (RUC)—the governing bodies that define code values and assign RVUs—giving the subspecialty a direct voice in how its clinical work is valued nationally.

Private Practice Structures and Revenue Growth

Ghali shifted the focus to private practice dynamics in 2026, outlining traditional partnership models, multi-specialty group employment, hybrid positions, and Private Equity (PE) acquisitions. In PE models, clinicians face distinct trade-offs: full buyouts offer reduced administrative burden at the expense of clinical autonomy, whereas hybrid partnerships allow physicians to reinvest roughly 40% equity to retain operational input, albeit with variable financial returns. 

In a typical Texas practice setting averaging 34 to 45 patient visits per day over 4.5 days, average collections hover around $120 per patient. Under a standard 40% collection-based compensation structure, this translates to $350,000 to $400,000 in gross physician earnings. 

To maintain work-life balance and expand margins beyond core evaluation and management (E/M) visits, Ghali recommended strategic revenue diversification: 

• Advanced Practice Providers (APPs): Currently employed by 75% of practices, APPs seeing 25 to 30 patients daily generate $75,000 to $100,000 in net practice revenue within traditional models, though PE and multi-specialty groups typically offer much lower supervisory splits (2%–5%). 
• Clinical Research: Integrating site management organizations (SMOs) allows practices to run trial protocols with lower administrative overhead; small sites managing 20 to 30 study patients yield $40,000 to $90,000 in net income. 
• Real Estate and Industry Engagement: Purchasing clinical space builds long-term equity, while participating in advisory boards or consulting ($2,000 per program average) provides additional non-clinical income.

Optimizing E/M and Procedural Coding

Chiu concluded the panel with a detailed look at coding nuances, emphasizing that under-coding leaves substantial legitimate revenue on the table. Level 3 E/M visits represent the absolute baseline for pediatric specialty encounters. Level 4 visits are easily reached when managing uncontrolled or progressive chronic conditions alongside prescription drug management. Furthermore, Level 5 coding is increasingly attainable for complex patients requiring multi-specialty record reviews, inter-provider care coordination, or therapeutic drug monitoring (e.g., methotrexate or isotretinoin). She also outlined key add-on codes and regulatory rules: 

• Code G2211: Currently reimbursed by Medicare and select private payers, this add-on code provides 0.33 additional work RVUs for ongoing longitudinal management of complex conditions, such as severe atopic dermatitis or vascular anomalies. 
• Supervision and Billing Rules: In physician practices, Incident-to billing allows APPs to bill under the physician's name at 100% reimbursement for established treatment plans. In hospital-based clinics, Split-Shared billing (Modifier -FS) can be utilized when the physician performs the medical decision-making portion of the encounter. 
• Procedural Intent and Modifiers: Coding for procedures depends heavily on documented clinical intent. Tangential biopsies (0.62 wRVUs) apply when evaluating lesions of uncertain diagnosis, whereas shave removals yield higher RVUs based on lesion size and anatomic location when the intent is complete excision of a symptomatic lesion. Physicians should consistently apply Modifier 25 when significant, separately identifiable E/M services occur on the same day as a procedure.

Dermatology Times is on-site in Minneapolis covering SPD’s latest updates from July 22 to 25th; view all our live conference coverage here. To keep up with all the exciting interviews, posters, and news, be sure to subscribe here and follow us on social media for more.